E. O. Tas Et Al. , "Investigating the impact of polysomy 17 in breast cancer patients with HER2 amplification through meta-analysis," TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4, pp.411-416, 2019
Tas, E. O. Et Al. 2019. Investigating the impact of polysomy 17 in breast cancer patients with HER2 amplification through meta-analysis. TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4 , 411-416.
Tas, E. O., Pala, E., ERCAN, İ., & ÖZEMRİ SAĞ, Ş., (2019). Investigating the impact of polysomy 17 in breast cancer patients with HER2 amplification through meta-analysis. TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4, 411-416.
Tas, Ezel Et Al. "Investigating the impact of polysomy 17 in breast cancer patients with HER2 amplification through meta-analysis," TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4, 411-416, 2019
Tas, Ezel O. Et Al. "Investigating the impact of polysomy 17 in breast cancer patients with HER2 amplification through meta-analysis." TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4, pp.411-416, 2019
Tas, E. O. Et Al. (2019) . "Investigating the impact of polysomy 17 in breast cancer patients with HER2 amplification through meta-analysis." TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4, pp.411-416.
@article{article, author={Ezel Ozge Tas Et Al. }, title={Investigating the impact of polysomy 17 in breast cancer patients with HER2 amplification through meta-analysis}, journal={TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI}, year=2019, pages={411-416} }